Complete Filing Data
RenovoRx, Inc. reported Stockholders Equity of $5.42 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean RenovoRx, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Net Income Loss | -$11.2M | -$8.8M | -$10.2M | -$9.9M | -$6.3M | -$3.8M |
| Research And Development Expense | $6.3M | $6.0M | $5.7M | $4.3M | $3.0M | $2.4M |
| Operating Income Loss | -$12.5M | -$11.0M | -$11.4M | -$10.0M | -$5.7M | -$3.2M |
| Operating Expenses | $13.3M | $11.0M | $11.4M | $10.0M | $5.7M | $3.2M |
| Nonoperating Income Expense | $1.3M | $2.2M | $1.2M | $61.0K | -$653.0K | -$594.0K |
| Interest Income Expense Nonoperating Net | $427.0K | $384.0K | $108.0K | $57.0K | -$834.0K | |
| General And Administrative Expense | $5.7M | $5.6M | $2.6M | $818.0K | ||
| Comprehensive Income Net Of Tax | -$11.2M | -$8.8M | -$10.2M | -$9.9M | -$6.3M | |
| Other Nonoperating Income Expense | $4.0K | $119.0K | -$7.0K | |||
| Other Comprehensive Income Loss Net Of Tax | -$17.0K | $17.0K | ||||
| Selling General And Administrative Expense | $7.0M | $5.0M | $5.7M | |||
| Other Comprehensive Income Loss Transfers From Held To Maturity To Available For Sale Securities Net Of Tax | $17.0K | |||||
| Revenues | $1.1M | $43.0K | ||||
| Gross Profit | $796.0K | $43.0K | ||||
| Income Taxes Paid Net | $1.0K | $2.0K | $38.0K | |||
| Cost Of Revenue | $327.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$2.9M | -$2.9M | -$2.4M | -$2.5M | -$2.4M | -$1.1M | -$1.4M | -$2.3M | -$3.3M | -$2.1M | -$2.6M | -$3.0M | -$1.5M | -$1.3M | -$1.1M | -$1.1M | -$773.0K | -$1.1M |
| Research And Development Expense | $1.7M | $1.4M | $1.6M | $1.7M | $1.5M | $1.3M | $1.6M | $1.9M | $1.3M | $846.0K | $1.4M | $1.3M | $767.0K | $536.0K | $635.0K | $727.0K | ||
| Operating Income Loss | -$3.2M | -$2.7M | -$3.1M | -$2.8M | -$3.0M | -$2.5M | -$3.0M | -$3.4M | -$3.3M | -$2.2M | -$2.6M | -$3.0M | -$1.4M | -$866.0K | -$1.1M | -$910.0K | ||
| Operating Expenses | $3.4M | $2.9M | $3.2M | $2.8M | $3.0M | $2.5M | $3.0M | $3.4M | $3.3M | $2.2M | $2.6M | $3.0M | $1.4M | $866.0K | $1.1M | $910.0K | ||
| Nonoperating Income Expense | $288.0K | -$217.0K | $690.0K | $357.0K | $645.0K | $1.4M | $1.6M | $1.0M | $4.0K | $25.0K | $20.0K | $2.0K | -$116.0K | -$444.0K | -$95.0K | -$186.0K | ||
| Interest Income Expense Nonoperating Net | $113.0K | $133.0K | $106.0K | $124.0K | $138.0K | $37.0K | $43.0K | $50.0K | $4.0K | $22.0K | $20.0K | $1.0K | -$208.0K | -$397.0K | ||||
| General And Administrative Expense | $1.2M | $1.5M | $1.2M | $1.4M | $1.5M | $1.9M | $1.3M | $1.2M | $1.7M | $628.0K | $330.0K | $418.0K | $183.0K | |||||
| Comprehensive Income Net Of Tax | -$2.4M | -$1.4M | -$2.3M | -$2.1M | -$2.6M | -$1.5M | -$1.3M | |||||||||||
| Other Nonoperating Income Expense | $3.0K | $1.0K | $170.0K | -$47.0K | -$5.0K | |||||||||||||
| Other Comprehensive Income Loss Net Of Tax | -$17.0K | $17.0K | -$4.0K | |||||||||||||||
| Selling General And Administrative Expense | $1.7M | $1.5M | $1.6M | $1.2M | $1.5M | $1.2M | ||||||||||||
| Other Comprehensive Income Loss Transfers From Held To Maturity To Available For Sale Securities Net Of Tax | $17.0K | -$4.0K | ||||||||||||||||
| Revenues | $266.0K | $422.0K | $197.0K | |||||||||||||||
| Gross Profit | $213.0K | $270.0K | $103.0K | |||||||||||||||
| Income Taxes Paid Net | $1.0K | |||||||||||||||||
| Cost Of Revenue | $53.0K | $152.0K | $94.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Stockholders Equity | $5.4M | $4.5M | $3.0M | $6.2M | $15.3M | -$14.7M | -$10.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $7.0M | $7.2M | $1.2M | $4.4M | $15.2M | $1.8M | $2.1M |
| Retained Earnings Accumulated Deficit | -$61.4M | -$50.2M | -$41.4M | -$31.2M | -$21.3M | -$15.0M | |
| Liabilities And Stockholders Equity | $8.1M | $8.1M | $1.5M | $7.3M | $16.3M | $1.9M | |
| Liabilities | $2.7M | $3.6M | $4.5M | $1.1M | $938.0K | $4.1M | |
| Common Stock Value | $4.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$130.0K | $6.0M | -$3.2M | -$10.8M | $13.4M | -$329.0K | |
| Cash And Cash Equivalents At Carrying Value | $7.0M | $7.2M | $1.2M | $4.4M | $15.2M | $1.8M | |
| Assets | $8.1M | $8.1M | $1.5M | $7.3M | $16.3M | $1.9M | |
| Accrued Liabilities Current | $1.2M | $1.3M | $614.0K | $568.0K | $413.0K | $311.0K | |
| Accounts Payable Current | $799.0K | $586.0K | $561.0K | $534.0K | $525.0K | $162.0K | |
| Prepaid Expense And Other Assets Current | $825.0K | $1.1M | $115.0K | ||||
| Liabilities Current | $2.0M | $1.9M | $1.2M | $1.1M | $938.0K | $4.1M | |
| Additional Paid In Capital Common Stock | $66.8M | $54.7M | $38.4M | $37.3M | $36.6M | ||
| Assets Current | $7.9M | $7.8M | $1.5M | $7.3M | $16.3M | $1.9M | |
| Change In Fair Value Of Common Warrant Liability | -$915.0K | -$1.8M | -$1.7M | ||||
| Fair Value Of Common Warrant Classified As Liability | $3.3M | ||||||
| Amortization On Leasehold Improvement | $6.0K | $9.0K | |||||
| Other Assets Current | $217.0K | $303.0K | $24.0K | ||||
| Property Plant And Equipment Net | $12.0K | $12.0K | |||||
| Operating Lease Right Of Use Asset | $190.0K | $278.0K | |||||
| Operating Lease Liability Noncurrent | $107.0K | $212.0K | |||||
| Deferred Offering Costs | $101.0K | ||||||
| Accounts Receivable Net Current | $139.0K | $43.0K | |||||
| Derivative Liability In Financing Activities | $738.0K | $743.0K | |||||
| Marketable Securities Current | $2.0M | ||||||
| Gains Losses On Extinguishment Of Debt | $62.0K | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $17.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $8.1M | $10.6M | $13.2M | $7.1M | $9.3M | $1.8M | $6.0K | $1.2M | $3.3M | $8.1M | $10.1M | $12.5M | $17.6M | -$17.1M | -$15.8M | -$13.8M | -$12.7M | -$11.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $10.0M | $12.3M | $14.6M | $9.6M | $11.7M | $4.4M | $3.2M | $6.0M | $3.7M | $3.1M | $2.8M | $13.1M | $17.7M | $1.6M | $837.0K | $2.3M | |||
| Retained Earnings Accumulated Deficit | -$58.4M | -$55.5M | -$52.6M | -$47.3M | -$44.9M | -$42.5M | -$38.2M | -$36.8M | -$34.4M | -$29.0M | -$26.9M | -$24.3M | -$18.9M | ||||||
| Liabilities And Stockholders Equity | $11.2M | $13.6M | $16.0M | $10.0M | $12.0M | $4.8M | $3.5M | $6.3M | $4.6M | $9.3M | $11.2M | $13.9M | $18.2M | ||||||
| Liabilities | $3.1M | $3.0M | $2.9M | $3.0M | $2.7M | $3.0M | $3.5M | $5.1M | $1.3M | $1.1M | $1.1M | $1.4M | $625.0K | ||||||
| Common Stock Value | $4.0K | $4.0K | $4.0K | $2.0K | $2.0K | $2.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $7.4M | $3.2M | -$668.0K | -$2.1M | -$958.0K | ||||||||||||||
| Cash And Cash Equivalents At Carrying Value | $10.0M | $12.3M | $14.6M | $9.6M | $11.7M | $4.4M | $3.2M | $6.0M | $3.7M | $3.1M | $2.8M | $13.1M | $17.7M | ||||||
| Assets | $11.2M | $13.6M | $16.0M | $10.0M | $12.0M | $4.8M | $3.5M | $6.3M | $4.6M | $9.3M | $11.2M | $13.9M | $18.2M | ||||||
| Accrued Liabilities Current | $1.0M | $885.0K | $769.0K | $1.1M | $873.0K | $737.0K | $1.3M | $827.0K | $477.0K | $564.0K | $650.0K | $677.0K | $492.0K | ||||||
| Accounts Payable Current | $869.0K | $671.0K | $967.0K | $686.0K | $438.0K | $356.0K | $350.0K | $872.0K | $828.0K | $538.0K | $473.0K | $729.0K | $133.0K | ||||||
| Prepaid Expense And Other Assets Current | $468.0K | $262.0K | $271.0K | $192.0K | $252.0K | $324.0K | $592.0K | $1.1M | $478.0K | $822.0K | $439.0K | ||||||||
| Liabilities Current | $1.9M | $1.6M | $1.7M | $1.8M | $1.3M | $1.1M | $1.6M | $1.7M | $625.0K | ||||||||||
| Additional Paid In Capital Common Stock | $66.5M | $66.2M | $65.8M | $38.2M | $37.9M | $37.7M | $37.2M | $37.0M | |||||||||||
| Assets Current | $11.0M | $13.4M | $15.7M | $9.3M | $11.2M | $13.9M | $18.2M | ||||||||||||
| Change In Fair Value Of Common Warrant Liability | -$584.0K | -$233.0K | -$507.0K | -$1.4M | -$1.5M | -$1.6M | |||||||||||||
| Fair Value Of Common Warrant Classified As Liability | $1.9M | ||||||||||||||||||
| Amortization On Leasehold Improvement | $3.0K | ||||||||||||||||||
| Other Assets Current | $145.0K | $288.0K | $444.0K | ||||||||||||||||
| Property Plant And Equipment Net | $13.0K | $13.0K | $13.0K | ||||||||||||||||
| Operating Lease Right Of Use Asset | $213.0K | $235.0K | $256.0K | ||||||||||||||||
| Operating Lease Liability Noncurrent | $134.0K | $161.0K | $186.0K | ||||||||||||||||
| Deferred Offering Costs | $128.0K | $41.0K | $36.0K | $246.0K | |||||||||||||||
| Accounts Receivable Net Current | $169.0K | $363.0K | $242.0K | ||||||||||||||||
| Derivative Liability In Financing Activities | $861.0K | ||||||||||||||||||
| Marketable Securities Current | $5.0M | $8.0M | |||||||||||||||||
| Gains Losses On Extinguishment Of Debt | -$78.0K | $140.0K | |||||||||||||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $13.0K | -$4.0K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $1.3M | $1.2M | $1.1M | $644.0K | $147.0K | $33.0K |
| Proceeds From Stock Options Exercised | $17.0K | $69.0K | $8.0K | $42.0K | $107.0K | $18.0K |
| Net Cash Provided By Used In Operating Activities | -$11.0M | -$9.1M | -$10.3M | -$8.8M | -$5.9M | -$3.5M |
| Net Cash Provided By Used In Financing Activities | $10.8M | $15.1M | $5.0M | $42.0K | $19.3M | $3.2M |
| Increase Decrease In Accrued Liabilities | -$265.0K | $636.0K | $46.0K | $155.0K | $342.0K | -$21.0K |
| Increase Decrease In Accounts Payable | $213.0K | $25.0K | $27.0K | $9.0K | $363.0K | -$376.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $160.0K | -$633.0K | -$264.0K | $970.0K | -$27.0K | |
| Net Cash Provided By Used In Investing Activities | -$2.0K | -$12.0K | $2.0M | -$2.0M | -$15.0K | |
| Increase Decrease In Other Operating Assets | $221.0K | $101.0K | -$9.0K | -$4.0K | ||
| Proceeds From Warrant Exercises | $25.0K | $33.0K | $2.7M | |||
| Proceeds From Issuance Of Common Stock | $12.1M | $17.2M | $5.0M | $14.6M | ||
| Increase Decrease In Deferred Offering Costs | ||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $6.0M | |||||
| Proceeds From Convertible Debt | $2.0M | $3.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $349.0K | $345.0K | $288.0K | $255.0K | $244.0K | $423.0K | $239.0K | $257.0K | $361.0K | $143.0K | $169.0K | $168.0K | $6.0K | $7.0K | $8.0K | $7.0K |
| Proceeds From Stock Options Exercised | $8.0K | $42.0K | $6.0K | $26.0K | $34.0K | |||||||||||
| Net Cash Provided By Used In Operating Activities | -$3.4M | -$2.2M | -$2.7M | -$2.1M | -$992.0K | |||||||||||
| Net Cash Provided By Used In Financing Activities | $10.8M | $5.4M | $6.0K | $26.0K | $34.0K | |||||||||||
| Increase Decrease In Accrued Liabilities | -$580.0K | $123.0K | -$91.0K | $264.0K | $102.0K | |||||||||||
| Increase Decrease In Accounts Payable | $381.0K | -$206.0K | $294.0K | $204.0K | $310.0K | |||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $149.0K | $53.0K | -$233.0K | -$267.0K | $1.0K | |||||||||||
| Net Cash Provided By Used In Investing Activities | -$2.0K | $2.0M | ||||||||||||||
| Increase Decrease In Other Operating Assets | $141.0K | $26.0K | $321.0K | |||||||||||||
| Proceeds From Warrant Exercises | ||||||||||||||||
| Proceeds From Issuance Of Common Stock | ||||||||||||||||
| Increase Decrease In Deferred Offering Costs | $27.0K | $246.0K | ||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $2.0M | |||||||||||||||
| Proceeds From Convertible Debt |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.32 | -$0.40 | -$0.99 | -$1.09 | -$1.21 | -$1.72 |
| Weighted Average Number Of Shares Outstanding Basic | 35.3M | 22.3M | 10.3M | 9.1M | 5.2M | |
| Earnings Per Share Basic | $-0.32 | $-0.40 | $-0.99 | $-1.09 | $-1.21 | |
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 42.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 36.6M | 24.0M | 10.7M | 9.1M | 8.9M | 2.2M |
| Weighted Average Number Of Diluted Shares Outstanding | 35.3M | 22.3M | 10.3M | 9.1M | ||
| Common Stock Shares Issued | 36.6M | 24.0M | 10.7M | 9.1M | 8.9M | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | ||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 15.0M | ||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.08 | -$0.08 | -$0.08 | -$0.10 | -$0.10 | -$0.07 | -$0.13 | -$0.22 | -$0.36 | -$0.24 | -$0.29 | -$0.27 | -$0.48 | ||||
| Weighted Average Number Of Shares Outstanding Basic | 36.6M | 36.6M | 31.4M | 24.9M | 24.0M | 14.9M | 10.7M | 10.7M | 9.1M | 9.1M | 9.1M | 9.0M | 5.6M | 2.3M | 2.2M | ||
| Earnings Per Share Basic | $-0.08 | $-0.08 | $-0.08 | $-0.10 | $-0.10 | $-0.07 | $-0.13 | $-0.22 | $-0.36 | $-0.24 | $-0.29 | $-0.33 | $-0.27 | $-0.57 | $-0.51 | ||
| Common Stock Shares Authorized | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 36.6M | 36.6M | 36.5M | 24.0M | 24.0M | 16.9M | 10.7M | 10.7M | 9.1M | 9.1M | 9.1M | 9.0M | 8.9M | ||||
| Weighted Average Number Of Diluted Shares Outstanding | 36.6M | 36.6M | 31.4M | 24.9M | 24.0M | 14.9M | 10.7M | 10.7M | 9.1M | 9.1M | 9.1M | ||||||
| Common Stock Shares Issued | 36.6M | 36.6M | 36.5M | 24.0M | 24.0M | 16.9M | 10.7M | 10.7M | 9.1M | 9.1M | 9.1M | 9.0M | 8.9M | 2.3M | |||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||||||||
| Preferred Stock Shares Authorized | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | 15.0M | |||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.3M | $1.2M | $1.1M | $630.0K | $147.0K | $33.0K |
| Stock Issued During Period Value Stock Options Exercised | $17.0K | $69.0K | $8.0K | $42.0K | $107.0K | $18.0K |
| Fair Value Adjustment Of Warrants | -$915.0K | -$1.8M | -$1.7M | |||
| Stock Issued During Period Shares Stock Options Exercised | 39.7K | 93.5K | 8.2K | 160.2K | 358.3K | |
| Shares Subject To Mandatory Redemption Settlement Terms Amount | 604.0K | 1.5M | 3.3M | |||
| Stock Issued During Period Value New Issues | $15.0M | $14.6M | ||||
| Stock Issued During Period Value Restricted Stock Award Gross | $14.0K | |||||
| Additional Paid In Capital | $303.0K | |||||
| Prepaid Expense Current | $324.0K | $328.0K | $168.0K | |||
| Stock Issued During Period Value Warrants Exercised | $25.0K | $33.0K | $2.7M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $349.0K | $345.0K | $288.0K | $255.0K | $244.0K | $423.0K | $239.0K | $257.0K | $244.0K | $143.0K | $169.0K | $154.0K | $6.0K | $7.0K | $8.0K | $7.0K | $8.0K | $10.0K | ||
| Stock Issued During Period Value Stock Options Exercised | $9.0K | $8.0K | $15.0K | $12.0K | $42.0K | $2.0K | $6.0K | $4.0K | $9.0K | $26.0K | $51.0K | $5.0K | $34.0K | $11.0K | ||||||
| Fair Value Adjustment Of Warrants | -$175.0K | $350.0K | -$584.0K | -$233.0K | -$507.0K | -$1.4M | ||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 6.8K | 39.0K | 3.5K | 91.8K | ||||||||||||||||
| Shares Subject To Mandatory Redemption Settlement Terms Amount | 1.1M | 1.3M | 935.0K | 1.2M | 1.4M | 1.9M | 1.9M | 3.4M | ||||||||||||
| Stock Issued During Period Value New Issues | $9.6M | $5.4M | $14.6M | |||||||||||||||||
| Stock Issued During Period Value Restricted Stock Award Gross | $117.0K | $14.0K | ||||||||||||||||||
| Additional Paid In Capital | $54.4M | $54.1M | $44.2M | $38.4M | $36.8M | $36.6M | $36.5M | |||||||||||||
| Prepaid Expense Current | $350.0K | $430.0K | $477.0K | |||||||||||||||||
| Stock Issued During Period Value Warrants Exercised | $25.0K | $2.7M |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 5, 2026.